Abstract
Atherosclerosis (AS) is the typical cardiovascular disease, which is the main underlying inducement of cardiovascular diseases. Aberrant expression of long noncoding RNA HLA complex group 11 (HCG11) was engaged with atherosclerosis. The objective of the present research was to explore the role and the potential mechanism of HCG11 in AS. Human umbilical vein endothelial cells (HUVECs) were stimulated with oxidized low-density lipoprotein (ox-LDL) to induce the AS model in vitro. The cell viability was detected by MTT assay. Flow cytometry was performed to determine cell pyroptosis. Gene and protein levels were detected by qPCR or Western blot assay. The interaction between HCG11, miR-224-3p, and Janus kinase 1 (JAK1) was validated by dual-luciferase reporter assays. Ox-LDL treatment aggravated cell pyroptosis and inflammation in HUVECs. And the levels of HCG11 and JAK1 was enhanced in ox-LDL-induced HUVECs, while miR-224-3p expression was reduced. Additionally, knockdown of HCG11 or miR-224-3p overexpression reversed the ox-LDL-induced cell viability decline and the increase of cell pyroptosis and inflammation-related proteins, including gasdermin D N-terminal (GSDMD-N), Caspase-1, NOD-like receptor family pyrin domain-containing 3 (NLRP3), interleukin 18 (IL-18), and interleukin 1beta (IL-1β). Moreover, HCG11 could modulate the JAK1 expression via targeting miR-224-3p. The inhibitory effect of HCG11 silencing on cell pyroptosis and inflammation was reversed by miR-224-3p knockdown. Furthermore, overexpression of miR-224-3p could repress the ox-LDL-induced cell pyroptosis and inflammation via regulating JAK1 expression. Knockdown of HCG11 alleviated cell pyroptosis and inflammation induced by ox-LDL via targeting the miR-224-3p/JAK1 axis, indicating that HCG11 could be the latent target of diagnosis or treatment for AS.
Similar content being viewed by others
Data Availability
The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
References
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sour**a T, Peto R, Collins R, Simes R, Trialists CT, C. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267–1278. https://doi.org/10.1016/S0140-6736(05)67394-1
Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, Lawes CM, Moran AE, Anderson LM, Roth GA, Mensah GA, Ezzati M, Murray CJ, Feigin VL, Global Burden of Diseases, Risk Factors Study Stroke Expert (2014) The global burden of ischemic stroke: findings of the GBD 2010 study. Glob Heart 9(1):107–112. https://doi.org/10.1016/j.gheart.2014.01.001
Bian W, **g X, Yang Z, Shi Z, Chen R, Xu A, Wang N, Jiang J, Yang C, Zhang D, Li L, Wang H, Wang J, Sun Y, Zhang C (2020) Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis. Aging (Albany NY) 12(7):6385–6400. https://doi.org/10.18632/aging.103034
Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ (2019) Peripheral artery disease: past, present, and future. Am J Med 132(10):1133–1141. https://doi.org/10.1016/j.amjmed.2019.04.043
Chen X, Liu G, Yuan Y, Wu G, Wang S, Yuan L (2019) NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-kappaB signaling. Cell Death Dis 10(12):906. https://doi.org/10.1038/s41419-019-2157-1
de Yebenes VG, Briones AM, Martos-Folgado I, Mur SM, Oller J, Bilal F, Gonzalez-Amor M, Mendez-Barbero N, Silla-Castro JC, Were F, Jimenez-Borreguero LJ, Sanchez-Cabo F, Bueno H, Salaices M, Redondo JM, Ramiro AR (2020) Aging-associated miR-217 aggravates atherosclerosis and promotes cardiovascular dysfunction. Arterioscler Thromb Vasc Biol 40(10):2408–2424. https://doi.org/10.1161/ATVBAHA.120.314333
Deng LT, Wang QL, Yu C, Gao M (2021) lncRNA PVT1 modulates NLRP3mediated pyroptosis in septic acute kidney injury by targeting miR20a5p. Mol Med Rep. https://doi.org/10.3892/mmr.2021.11910
Du J, Han R, Li Y, Liu X, Liu S, Cai Z, Xu Z, Li Y, Yuan X, Guo X, Lu B, Sun K (2020) LncRNA HCG11/miR-26b-5p/QKI5 feedback loop reversed high glucose-induced proliferation and angiogenesis inhibition of HUVECs. J Cell Mol Med 24(24):14231–14246. https://doi.org/10.1111/jcmm.16040
Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47(8 Suppl):C7-12. https://doi.org/10.1016/j.jacc.2005.09.068
Gao C, Yan Y, Chen G, Wang T, Luo C, Zhang M, Chen X, Tao L (2020) Autophagy activation represses pyroptosis through the IL-13 and JAK1/STAT1 pathways in a mouse model of moderate traumatic brain injury. ACS Chem Neurosci 11(24):4231–4239. https://doi.org/10.1021/acschemneuro.0c00517
Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12(3):204–212. https://doi.org/10.1038/ni.2001
Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S (2016) Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 118(4):535–546. https://doi.org/10.1161/CIRCRESAHA.115.307611
Jian D, Dai B, Hu X, Yao Q, Zheng C, Zhu J (2017) ox-LDL increases microRNA-29a transcription through upregulating YY1 and STAT1 in macrophages. Cell Biol Int 41(9):1001–1011. https://doi.org/10.1002/cbin.10803
Kattoor AJ, Kanuri SH, Mehta JL (2019) Role of Ox-LDL and LOX-1 in atherogenesis. Curr Med Chem 26(9):1693–1700. https://doi.org/10.2174/0929867325666180508100950
Kovacs SB, Miao EA (2017) Gasdermins: effectors of pyroptosis. Trends Cell Biol 27(9):673–684. https://doi.org/10.1016/j.tcb.2017.05.005
Li FP, Lin DQ, Gao LY (2018) LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA-21/PTEN axis. Eur Rev Med Pharmacol Sci 22(21):7439–7447. https://doi.org/10.26355/eurrev_201811_16284
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, Lieberman J (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535(7610):153–158. https://doi.org/10.1038/nature18629
Liu Y, Cui X, Wang C, Zhao S (2020) LncRNA HCG11 regulates proliferation and apoptosis of vascular smooth muscle cell through targeting miR-144-3p/FOXF1 axis in atherosclerosis. Biol Res 53(1):44. https://doi.org/10.1186/s40659-020-00306-2
Ma Y, Tang T, Sheng L, Wang Z, Tao H, Zhang Q, Zhang Y, Qi Z (2018) Aloin suppresses lipopolysaccharideinduced inflammation by inhibiting JAK1STAT1/3 activation and ROS production in RAW264.7 cells. Int J Mol Med 42(4):1925–1934. https://doi.org/10.3892/ijmm.2018.3796
Man SM, Karki R, Kanneganti TD (2017) Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 277(1):61–75. https://doi.org/10.1111/imr.12534
Meng Q, Li Y, Ji T, Chao Y, Li J, Fu Y, Wang S, Chen Q, Chen W, Huang F, Wang Y, Zhang Q, Wang X, Bian H (2021) Estrogen prevent atherosclerosis by attenuating endothelial cell pyroptosis via activation of estrogen receptor alpha-mediated autophagy. J Adv Res 28:149–164. https://doi.org/10.1016/j.jare.2020.08.010
Miotto M, Marinari E, De Martino A (2019) Competing endogenous RNA crosstalk at system level. PLoS Comput Biol 15(11):e1007474. https://doi.org/10.1371/journal.pcbi.1007474
Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M (2014) Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the global burden of disease 2010 study. Circulation 129(14):1483–1492. https://doi.org/10.1161/CIRCULATIONAHA.113.004042
Mori H, Torii S, Kutyna M, Sakamoto A, Finn AV, Virmani R (2018) Coronary artery calcification and its progression: what does it really mean? JACC Cardiovasc Imaging 11(1):127–142. https://doi.org/10.1016/j.jcmg.2017.10.012
Nilsson J, Nordin Fredrikson G, Schiopu A, Shah PK, Jansson B, Carlsson R (2007) Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease. Curr Pharm Des 13(10):1021–1030. https://doi.org/10.2174/138161207780487557
Palasubramaniam J, Wang X, Peter K (2019) Myocardial infarction-from atherosclerosis to thrombosis. Arterioscler Thromb Vasc Biol 39(8):e176–e185. https://doi.org/10.1161/ATVBAHA.119.312578
Pan JX (2017) LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci 21(2):322–328
Qian Z, Zhao Y, Wan C, Deng Y, Zhuang Y, Xu Y, Zhu Y, Lu S, Bao Z (2021) Pyroptosis in the initiation and progression of atherosclerosis. Front Pharmacol 12:652963. https://doi.org/10.3389/fphar.2021.652963
Qiao L, Wu X, Zhang J, Liu L, Sui X, Zhang R, Liu W, Shen F, Sun Y, ** X (2019) Alpha-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway. FASEB J 33(11):12760–12767. https://doi.org/10.1096/fj.201900483RR
Ruiz-Leon AM, Lapuente M, Estruch R, Casas R (2019) Clinical advances in immunonutrition and atherosclerosis: a review. Front Immunol 10:837. https://doi.org/10.3389/fimmu.2019.00837
Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RT, Heyll K, Noels H, Hristov M, Wang S, Kiessling F, Olson EN, Weber C (2014) MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 20(4):368–376. https://doi.org/10.1038/nm.3487
Simon LS, Taylor PC, Choy EH, Sebba A, Quebe A, Knopp KL, Porreca F (2021) The Jak/STAT pathway: a focus on pain in rheumatoid arthritis. Semin Arthritis Rheum 51(1):278–284. https://doi.org/10.1016/j.semarthrit.2020.10.008
Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr (2004) Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292(15):1845–1852. https://doi.org/10.1001/jama.292.15.1845
Sun L, He X, Zhang T, Tao G, Wang X (2021) Knockdown of lnc-KCNC3-3:1 alleviates the development of atherosclerosis via downregulation of JAK1/STAT3 signaling pathway. Front Cardiovasc Med 8:701058. https://doi.org/10.3389/fcvm.2021.701058
Vigen T, Ihle-Hansen H, Lyngbakken MN, Berge T, Thommessen B, Ihle-Hansen H, Orstad EB, Enger S, Rosjo H, Tveit A, Ronning OM (2020) Carotid atherosclerosis is associated with middle cerebral artery pulsatility index. J Neuroimaging 30(2):233–239. https://doi.org/10.1111/jon.12684
Wang Y, Han Z, Fan Y, Zhang J, Chen K, Gao L, Zeng H, Cao J, Wang C (2017) MicroRNA-9 Inhibits NLRP3 inflammasome activation in human atherosclerosis inflammation cell models through the JAK1/STAT signaling pathway. Cell Physiol Biochem 41(4):1555–1571. https://doi.org/10.1159/000470822
Wang C, Niimi M, Watanabe T, Wang Y, Liang J, Fan J (2018a) Treatment of atherosclerosis by traditional chinese medicine: questions and quandaries. Atherosclerosis 277:136–144. https://doi.org/10.1016/j.atherosclerosis.2018.08.039
Wang F, Liu B, Yu Z, Wang T, Song Y, Zhuang R, Wu Y, Su Y, Guo S (2018b) Effects of CD100 promote wound healing in diabetic mice. J Mol Histol 49(3):277–287. https://doi.org/10.1007/s10735-018-9767-2
Wang Q, Wu J, Zeng Y, Chen K, Wang C, Yang S, Sun N, Chen H, Duan K, Zeng G (2020) Pyroptosis: a pro-inflammatory type of cell death in cardiovascular disease. Clin Chim Acta 510:62–72. https://doi.org/10.1016/j.cca.2020.06.044
Wang H, Sugimoto K, Lu H, Yang WY, Liu JY, Yang HY, Song YB, Yan D, Zou TY, Shen S (2021a) HDAC1-mediated deacetylation of HIF1alpha prevents atherosclerosis progression by promoting miR-224-3p-mediated inhibition of FOSL2. Mol Ther Nucleic Acids 23:577–591. https://doi.org/10.1016/j.omtn.2020.10.044
Wang S, Li J, Chen A, Song H (2021b) Differentiated expression of long non-coding RNA-small nucleolar RNA host gene 8 in atherosclerosis and its molecular mechanism. Bioengineered 12(1):7167–7176. https://doi.org/10.1080/21655979.2021.1979441
Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124(2):315–327. https://doi.org/10.1161/CIRCRESAHA.118.313591
Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z, Lin Y, Bai X, Liu X, Chen X, Yang H, Xu C, Zhang Y, Yang B (2018) Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis 9(2):171. https://doi.org/10.1038/s41419-017-0257-3
**ng SS, Yang J, Li WJ, Li J, Chen L, Yang YT, Lei X, Li J, Wang K, Liu X (2020) Salidroside decreases atherosclerosis plaque formation via inhibiting endothelial cell pyroptosis. Inflammation 43(2):433–440. https://doi.org/10.1007/s10753-019-01106-x
Yan H, Wang S, Li Z, Zhao W, Wang Z, Sun Z, Pan Y, Zhu J (2016) Upregulation of miRNA-155 expression by OxLDL in dendritic cells involves JAK1/2 kinase and transcription factors YY1 and MYB. Int J Mol Med 37(5):1371–1378. https://doi.org/10.3892/ijmm.2016.2526
Ye ZM, Yang S, **a YP, Hu RT, Chen S, Li BW, Chen SL, Luo XY, Mao L, Li Y, ** H, Qin C, Hu B (2019) LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis 10(2):138. https://doi.org/10.1038/s41419-019-1409-4
Yu XH, Deng WY, Chen JJ, Xu XD, Liu XX, Chen L, Shi MW, Liu QX, Tao M, Ren K (2020) LncRNA kcnq1ot1 promotes lipid accumulation and accelerates atherosclerosis via functioning as a ceRNA through the miR-452-3p/HDAC3/ABCA1 axis. Cell Death Dis 11(12):1043. https://doi.org/10.1038/s41419-020-03263-6
Zhai C, Sun Y, Qian G, Pan H, **e S, Sun Z, Zhang S, Hu H (2021) LncRNA AK087124/miR-224-5p/PTEN axis modulates endothelial cell injury in atherosclerosis through apoptosis and AKT signaling pathway. Arch Biochem Biophys 705:108916. https://doi.org/10.1016/j.abb.2021.108916
Zhang K, Shi Z, Zhang M, Dong X, Zheng L, Li G, Han X, Yao Z, Han T, Hong W (2020) Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis 11(2):132. https://doi.org/10.1038/s41419-020-2323-5
Zhaolin Z, Guohua L, Shiyuan W, Zuo W (2019a) Role of pyroptosis in cardiovascular disease. Cell Prolif 52(2):e12563. https://doi.org/10.1111/cpr.12563
Zhaolin Z, Jiaojiao C, Peng W, Yami L, Tingting Z, Jun T, Shiyuan W, **yan X, Dangheng W, Zhisheng J, Zuo W (2019b) OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway. J Cell Physiol 234(5):7475–7491. https://doi.org/10.1002/jcp.27509
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhou, H., Song, WH. LncRNA HCG11 Accelerates Atherosclerosis via Regulating the miR-224-3p/JAK1 Axis. Biochem Genet 61, 372–389 (2023). https://doi.org/10.1007/s10528-022-10261-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-022-10261-0